Guardant Health
GH
#2990
Rank
NZ$7.42 B
Marketcap
$60.12
Share price
6.26%
Change (1 day)
48.79%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company